Chongqing Zhifei Biological Products | Sustainability Performance
Focuses on the research, production, and distribution of vaccines and biological products.
2001
China
5,001 - 10,000 employees
Biotechnology
$1B - 10B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#11602
Overallⓘ#908
in Chinaⓘ#238
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Critical
Leading
Aligned
Intensity
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Industry Benchmark
171.8
B/M 41.5
305.3
B/M 138.6
Powered by illuminem and GIST Impact
Controversy level
- Chongqing Zhifei Biological Products has faced periodic Chinese NMPA scrutiny over vaccine product practices, plus the broader Chinese vaccine industry quality compliance challenges following multiple historic scandals.
